Latest News

If you are considering whether Colliers International Group at around CA$158.60 offers value or risk at this point in the cycle, this overview helps put the current share price in context before you make any decisions. The stock has recently moved 1.4% over the last 7 days and 13.0% over the last 30 days, while the year-to-date return is a 20.5% decline and the 1-year return is a 1.0% decline. The 3-year and 5-year returns are 16.3% and 23.9% respectively. Recent coverage has focused on how...

New Nantong subsidiary adds ship repair focus to Yangzijiang Shipbuilding (Holdings) (SGX:BS6) Yangzijiang Shipbuilding (Holdings) (SGX:BS6) has set up Jiangsu Yangzi Hongda Shipbuilding and Repair Co. Ltd. in Nantong City with registered capital of US$100 million, fully funded from internal resources. The new wholly owned unit will develop and operate facilities for large vessel delivery, repair and conversion services to support the group’s operations and business development. Management...

If you are considering whether Everpure at US$69.36 is still a sensible entry point or if the easier gains may have already occurred, this breakdown can help you compare the current price with the underlying value. The stock has delivered returns of 6.9% over 7 days, 7.6% over 30 days, 0.5% year to date and 62.4% over the past year, with a 3-year return of 206.2% and a 5-year return of 233.0%. Recent news coverage has focused on Everpure's position within the broader Tech sector and on how...

Stifel Financial (SF) opened 2026 with Q1 revenue of US$1.5b and basic EPS of US$1.56, setting the tone against a share price of US$77.37. The company reported quarterly revenue of US$1.24b in Q1 2025 and US$1.47b in Q1 2026, while basic EPS increased from US$0.28 to US$1.56 over the same period. On a trailing twelve month basis, EPS was US$5.46 on revenue of US$5.7b. For investors, the key point is that higher earnings are now associated with a wider profit margin profile, which puts...

Why Freshworks’ New Partnership Leader Matters for Stock Watchers Freshworks (FRSH) has drawn fresh attention after appointing Kuntal Vahalia as Senior Vice President, Partnership Channel, a move aimed at sharpening its global partner strategy and focus on employee experience offerings. See our latest analysis for Freshworks. Freshworks’ recent executive hire comes as the shares trade at US$8.91, with a 7 day share price return of 7.87% and a 30 day gain of 9.06%. However, the 1 year total...

With iQIYI trading at US$1.25, many investors are asking whether the current price reflects the underlying value of the business or if the market is being too harsh. Over the last week, the share price return was 11.3% lower, while the 1 year return was 33.2% lower and the 5 year return was 91.9% lower. Together, these figures can change how the market views both risk and potential reward. Recent coverage around iQIYI has focused on how investors interpret these longer term share price moves,...

Reliance Industrial Infrastructure Limited ( NSE:RIIL ) just released a solid earnings report, and the stock displayed...

One thing we could say about the analysts on Transformers and Rectifiers (India) Limited ( NSE:TARIL ) - they aren't...

Old National Bancorp (ONB) opened 2026 with Q1 revenue of US$652.9 million and basic EPS of US$0.60, while trailing 12 month revenue and EPS came in at US$2.5 billion and US$1.95 respectively as the bank continued to convert its top line into earnings. Over recent quarters, revenue has ranged from US$446.6 million in Q1 2025 to US$671.3 million in Q3 2025, with basic EPS moving between US$0.34 and US$0.60 across the same period. This gives investors a clear read on how earnings track...

Finnair Oyj (HLSE:FIA1S) opened 2026 with Q1 revenue of €820.9 million, a basic EPS loss of €0.04 and net income loss of €9.2 million, setting a cautious tone for investors weighing the latest numbers against thin trailing profitability. Over recent quarters the company has seen revenue move from €694.2 million in Q1 2025 to €789.5 million in Q4 2025 and then to €820.9 million in Q1 2026. Quarterly basic EPS has ranged from a loss of €0.25 in Q1 2025 to a profit of €0.13 in Q4 2025 before...

Community Health Systems (CYH) opened 2026 with Q1 revenue of US$2.97b and a basic EPS loss of US$0.43, as net income excluding extra items came in at a loss of US$58m. The company has seen recent quarterly revenue move from US$3.27b in Q4 2024 to US$3.13b in Q2 2025, US$3.09b in Q3 2025, US$3.11b in Q4 2025 and then US$2.97b in Q1 2026. Basic EPS has ranged from a loss of US$0.53 in Q4 2024 to a peak of US$2.11 in Q2 2025 before swinging back into a loss this quarter. For investors, the mix...

Wondering whether Repsol's current share price truly reflects its underlying worth, or if the market is missing something that you should not. Repsol shares last closed at €21.23, with returns of 3.5% over 7 days, a 6.4% decline over 30 days, 29.4% year to date, 114.8% over 1 year, 81.8% over 3 years and 164.5% over 5 years. Recent coverage has focused on Repsol's position as a major integrated energy player and how investor attention on the sector has shifted in light of energy pricing and...

Pegasystems (PEGA) opened Q1 2026 with revenue of US$430 million and basic EPS of US$0.19, against a backdrop of reported 73.2% earnings growth over the last twelve months and a trailing net profit margin of 20% compared with 12% in the prior year. Over recent quarters the company has seen revenue move from US$476 million in Q1 2025 to US$504 million in Q4 2025 and EPS range from US$0.18 to US$1.38, feeding into trailing twelve month EPS of US$2.00 on revenue of about US$1.7 billion. For...

Bristol Myers Squibb (NYSE:BMY) has expanded its collaboration with Foundation Medicine to develop a next generation sequencing companion diagnostic to identify patients with homozygous MTAP deletion. The company has also agreed to source 145 MW of solar power from Geronimo Power's 270 MW Blevins Solar Project as part of a long term sustainability initiative. Bristol Myers Squibb, recently trading around $58.8, has drawn fresh attention with these twin moves in precision oncology and...

New Oriental Education & Technology Group (EDU) has reported a busy Q3 2026, with revenue of US$1.4b and basic EPS of US$0.80, as investors weigh these quarterly figures against a trailing twelve month EPS of US$2.65 on revenue of US$5.4b. Over recent quarters the company has seen revenue move from US$1.0b in Q2 2025 to US$1.4b in Q3 2026, while basic EPS has ranged from US$0.20 to US$1.52 across that stretch. This release is another checkpoint on how consistently the company can convert its...

Bar Harbor Bankshares (BHB) opened 2026 with Q1 revenue of US$46.8 million and basic EPS of US$0.81, backed by net income of US$13.5 million as the bank continued to generate earnings on a loan book of about US$3.6 billion. Over recent quarters, revenue has ranged from US$34.0 million to US$48.2 million, while basic EPS has moved between roughly US$0.40 and US$0.81. This gives investors a clearer view of how the income statement responds to shifts in activity and funding costs. With a...

If you are wondering whether Target's current share price lines up with its underlying worth, the recent numbers give you plenty to think about. The stock last closed at US$130.60, with returns of 6.3% over the past week, 13.6% over the past month, 29.9% year to date and 48.2% over the last year, while the 3 year and 5 year returns sit at 6.4% and 26.1% declines respectively. These mixed return figures have arrived alongside ongoing attention on how Target is positioning itself within...

If you are wondering whether Teva Pharmaceutical Industries at about US$31.22 is still reasonably priced after its strong run, the next sections walk through what the current market price may be implying. The stock has returned 8.5% over the last 30 days and 118.5% over the last year, while year to date the move sits at 0.9% and the 7 day return is a 1.2% decline. Recent news flow around Teva has focused on its position in the broader pharmaceuticals sector and ongoing investor interest in...

Triumph Financial (TFIN) kicked off Q1 2026 with total revenue of US$106.4 million and basic EPS of US$0.23, set against trailing twelve month revenue of US$442.0 million and basic EPS of US$1.23. This came alongside a higher net profit margin of 6.4% compared with 2.2% in the prior year. Over recent quarters, revenue has moved from US$99.1 million in Q4 2024 to US$100.2 million in Q1 2025, US$108.8 million in Q2 2025, US$105.0 million in Q3 2025, US$121.8 million in Q4 2025, and now US$106.4...

AstraZeneca reported positive Phase III trial results for Ultomiris in immunoglobulin A nephropathy (IgAN). The company also announced strong late stage data for tozorakimab in chronic obstructive pulmonary disease (COPD). AstraZeneca plans to seek regulatory approvals for both therapies following these outcomes. The updates highlight progress in expanding its portfolio in rare kidney and chronic respiratory diseases. AstraZeneca (LSE:AZN), trading at about £145.36, has seen its share price...

FTI Consulting stock moves alongside recent return profile With no single headline event setting the tone, FTI Consulting (FCN) has drawn attention as investors weigh its recent share moves, including a 1 day decline and gains over the week, month and past 3 months. See our latest analysis for FTI Consulting. At a share price of $185.32, FTI Consulting sits on an 8.83% year to date share price return and a 9.98% 1 year total shareholder return, while the 3 year total shareholder return of a...

Hancock Whitney (HWC) kicked off Q1 2026 with total revenue of US$279.5 million and basic EPS of US$0.58, alongside trailing twelve month revenue of US$1.4 billion and EPS of US$4.92, giving investors a fresh read on both quarterly and rolling earnings power. Over the last few reported quarters, revenue has ranged from US$351.3 million to US$375.1 million while EPS moved between roughly US$1.32 and US$1.51, so this latest print lands against a backdrop of higher trailing revenue and earnings...

WELL Health Technologies (TSX:WELL) has reported record patient visits across its network. The company is reporting significant EBITDA margin expansion in its primary care segment. WELL is continuing to grow its Affiliate Clinic network in partnership with a large retailer. For investors tracking healthcare operators, TSX:WELL is drawing attention with these operational milestones and a current share price of CA$4.27. The company has a mixed return profile, with the share price up 14.5%...

Setting the scene: AT&T’s latest numbers in focus AT&T (T) opened 2026 with Q1 revenue of US$31.5 billion and basic EPS of US$0.55, setting the tone for how its earnings story is evolving after a year of margin improvement. The company has seen quarterly revenue move from US$30.6 billion in Q1 2025 to US$31.5 billion in Q1 2026, while basic EPS shifted from US$0.61 to US$0.55 over the same period, against a trailing twelve month EPS of about US$3.01. For investors, the headline is that...